Reuters logo
BRIEF-Egalet announces filing of supplemental new drug application for Oxaydo to U.S. FDA
December 1, 2016 / 6:55 PM / in a year

BRIEF-Egalet announces filing of supplemental new drug application for Oxaydo to U.S. FDA

Dec 1 (Reuters) - Egalet Corp :

* Egalet announces filing of supplemental new drug application for Oxaydo to FDA

* sNDA for Oxaydo includes data from a series of category 1 studies that were presented at Painweek 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below